• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

La Jolla Pharmaceutical Co

+ Add to Watchlist

LJPC:US

11.2600 USD 0.1400 1.26%

As of 20:10:00 ET on 07/25/2014.

Snapshot for La Jolla Pharmaceutical Co (LJPC)

Open: 11.0400 Day's Range: 10.6500 - 11.4500 Volume: 204,006
Previous Close: 11.1200 52wk Range: 2.7844 - 19.5000 1-Yr Rtn: +279.28%

Stock Chart for LJPC

No chart data available.
  • LJPC:US 11.2600
  • 1D
  • 1M
  • 1Y
11.1200
Interactive LJPC Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for LJPC

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.4616
Est. EPS (USD) (12/2014) -3.2470
Est. PEG Ratio -
Market Cap (M USD) 142.63
Shares Outstanding (M) 12.67
30 Day Average Volume 244,270
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/01/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for LJPC

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for LJPC

La Jolla Pharmaceutical Company researches and develops specialized therapeutics for the treatment of diseases caused by antibodies. The Company is developing products to treat autoimmune conditions such as lupus and antibody-mediated stroke.

George F TidmarshPresident/CEO/SecretaryJames RolkeSenior Dir:Research & Dev
Chester S Zygmont IIIDirector:Finance
More Company Profile & Key Executives for LJPC

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil